## Clinical Assessment This patient presents with classic Guillain-Barré Syndrome (GBS) — ascending paralysis, areflexia, and antecedent infection. The critical finding is **vital capacity of 65%**, indicating significant respiratory compromise risk. ## Why ICU Admission with Monitoring is the Next Step **Key Point:** Respiratory failure is the leading cause of mortality in GBS. Vital capacity <70% of predicted is a strong predictor of need for mechanical ventilation within 24–48 hours. **High-Yield:** The immediate priority in GBS with borderline respiratory function is: 1. ICU-level monitoring (continuous pulse oximetry, capnography) 2. Serial vital capacity measurements (every 4–6 hours) 3. Prepare for intubation (have equipment, anesthesia on standby) 4. Initiate immunotherapy *after* stabilization is assured **Clinical Pearl:** Immunotherapy (IVIG or plasmapheresis) should NOT delay respiratory support preparation. Both can be started in ICU once the patient is stabilized and monitored. ## Timeline of GBS Management ```mermaid flowchart TD A[GBS diagnosis confirmed]:::outcome --> B{Vital capacity?}:::decision B -->|>80% predicted| C[Ward admission, monitor VC q12h]:::action B -->|60-80% predicted| D[ICU admission, VC q4-6h, prep intubation]:::action B -->|<60% predicted| E[Intubate prophylactically]:::urgent D --> F[Start IVIG or plasmapheresis]:::action C --> F E --> F F --> G[Supportive care, rehabilitation]:::action ``` **Mnemonic:** **RIM** — Respiratory support first, then Immunotherapy, then Monitoring for complications. **Warning:** Starting IVIG while the patient is hypoxic or unmonitored is dangerous. Respiratory failure can develop rapidly and unpredictably in GBS. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.